- Home
- GAUZ vs COEP Comparison
GAUZ vs COEP Comparison
Compare GAUZ & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GAUZ
- COEP
- Stock Information
- Founded
- GAUZ 2009
- COEP 2017
- Country
- GAUZ Israel
- COEP United States
- Employees
- GAUZ N/A
- COEP N/A
- Industry
- GAUZ Industrial Machinery/Components
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GAUZ Miscellaneous
- COEP Health Care
- Exchange
- GAUZ Nasdaq
- COEP Nasdaq
- Market Cap
- GAUZ 102.0M
- COEP 86.0M
- IPO Year
- GAUZ 2024
- COEP N/A
- Fundamental
- Price
- GAUZ $5.91
- COEP $14.96
- Analyst Decision
- GAUZ Strong Buy
- COEP
- Analyst Count
- GAUZ 3
- COEP 0
- Target Price
- GAUZ $13.67
- COEP N/A
- AVG Volume (30 Days)
- GAUZ 31.3K
- COEP 39.8K
- Earning Date
- GAUZ 11-13-2025
- COEP 11-10-2025
- Dividend Yield
- GAUZ N/A
- COEP N/A
- EPS Growth
- GAUZ N/A
- COEP N/A
- EPS
- GAUZ N/A
- COEP N/A
- Revenue
- GAUZ $96,810,000.00
- COEP $263,555.00
- Revenue This Year
- GAUZ $22.59
- COEP N/A
- Revenue Next Year
- GAUZ $41.48
- COEP N/A
- P/E Ratio
- GAUZ N/A
- COEP N/A
- Revenue Growth
- GAUZ 7.87
- COEP N/A
- 52 Week Low
- GAUZ $4.54
- COEP $2.31
- 52 Week High
- GAUZ $13.00
- COEP $19.19
- Technical
- Relative Strength Index (RSI)
- GAUZ 42.47
- COEP 47.93
- Support Level
- GAUZ $6.06
- COEP $14.68
- Resistance Level
- GAUZ $6.59
- COEP $16.45
- Average True Range (ATR)
- GAUZ 0.40
- COEP 0.83
- MACD
- GAUZ -0.09
- COEP -0.17
- Stochastic Oscillator
- GAUZ 13.50
- COEP 15.42
About GAUZ Gauzy Ltd. Ordinary Shares
Gauzy Ltd is a fully integrated light and vision control company. Its products include suspended particle device and liquid crystal materials for smart glass applications and AI-powered driver assistance systems, or ADAS, solutions including camera monitoring systems. The company's operating segments are Architecture, Automotive, Safety tech, and Aeronautics. Maximum revenue is generated from its Safety tech segment, which focuses on sales of driver assistance systems for buses, coaches, recreational vehicles, and specific vehicles, such as camera and motion sensor systems, smart mirrors, and safety doors. Geographically, it derives maximum revenue from other European countries (excluding France), followed by the United States, France, Asia, Israel, and other regions.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.